Karen Flynn, Senior Vice President and Chief Commercial Officer, West Pharmaceutical Services, in an interaction with Sachin Jagdale, divulges the company's growth prospects for the Indian market
Your Chennai plant was expected to generate profits by early 2016. What is the current status? What plans have been chalked out to expand production at the site to include elastomer components?
We are pleased with the progress of our Chennai plant and it is developing in line with our overall strategic plan for the company, which also includes greater geographic expansion in the coming years. Currently, the facility is fully operational and manufacturing various offerings from our product portfolio of seals.
The site was built to spur expansion. and we do have space to grow. In addition to accommodating more seals business, there’s potential to produce other West product offerings in response to regional market demands.
What are the India-specific challenges for your company? What are the major gains for West Pharmaceutical Services since its inception in India?
Many of the challenges we see in India are similar to what our customers are experiencing across the globe. First, there is a need for high quality components to meet increased regulatory scrutiny. Also, speed to market is an important factor for our customers. To help customers bring their products to market faster, we established a comprehensive global supply chain network that includes the necessary infrastructure for the Asia Pacific region.
Since the inception of West Pharmaceutical Services in India, we have partnered with pharma and biotech companies who have injectable product portfolios that align with our packaging and delivery offerings. Today, injectable formulations are one of the fastest growing dosage forms in India due to investments in injectable dosage form manufacturing facilities and the progression of biosimilars to commercial products.
ãã®èšäºã¯ Express Pharma ã® July 16-31, 2016 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã ?  ãµã€ã³ã€ã³
ãã®èšäºã¯ Express Pharma ã® July 16-31, 2016 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã? ãµã€ã³ã€ã³
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation
